PorTal Access Secures FDA Clearance for FLEXI-PORT Vascular Access Ports
June 23, 2026
The power-injectable implantable port system is designed to support long-term vascular access in adult and paediatric patients.
The power-injectable implantable port system is designed to support long-term vascular access in adult and paediatric patients.
AorticLab announced today that its FLOWer device received CE mark approval for extended use in transcatheter cardiovascular procedures.
LEM Surgical announced today that the FDA granted a new 510(k) clearance for its Dynamis robotic surgical system.
Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
Researchers at The University of Alabama in Huntsville (UAH), a part of The University of Alabama System, have published new findings suggesting continuous low-intensity ultrasound may help shift the body’s immune response from prolonged inflammation toward tissue repair, a discovery that could eventually contribute to novel treatments for joint injuries and post-traumatic osteoarthritis.
Researchers have now found a way to turn this emergency into a tool to protect the body from the devastating effects of another health emergency—a stroke.
In partnership with Gemini Untwined, XRlabs’ Surgical Intelligence platform generated custom implants in seconds and enabled successful craniopagus twin separation
Spiraling waves of neural activity appear and travel in the brain. Scientists hope to learn if these rotating waves on the move play a global role in sensing and interpreting internal and external stimuli, in laying down memory and in managing motor performance.
FiberSense has announced that its Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is intended for continuous monitoring of blood sugar levels and glucose trends in adults with diabetes.
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.